Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page no longer displays the study's disease label 'Prostate cancer' and the related topics entry 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page now lists Prostate cancer and MedlinePlus Genetics under related topics, surfacing disease context and genetics resources alongside the study details.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page now displays Revision: v3.6.3, and earlier references such as Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.6.0 have been removed.SummaryDifference0.2%

- Check25 days agoChange DetectedThe study page gains explicit tagging for Prostate cancer and a related topic entry for MedlinePlus Genetics. This links the content to disease-specific and genetics resources.SummaryDifference0.2%

- Check32 days agoChange DetectedNew help and navigation sections were added to the study page (How to Read a Study Record, Common Questions, How to Join a Study). A recruitment status note No longer looking for participants was added, and the Intervention/Treatment heading was reformatted, with an updated revision tag to v3.6.0.SummaryDifference0.4%

- Check39 days agoChange DetectedAdded a new protocol revision tag v3.5.5 and refreshed study record dates. Older revision/date entries (v3.5.4 and earlier dates) were removed.SummaryDifference0.3%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.